Donald Haut

The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

Arthrosurface, Inc. engage sin the design and distribution of orthopedic devices for joint preservation, restoration, and resurfacing. It offers HemiCAP system that can be use to treat a variety of joint conditions caused by trauma, injury, and disease. The company was founded by Steven W. Ek, Andrea Patisteas, and Steven J. Tallarida in 2002 and is headquartered in Franklin, MA.

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Xiros Ltd. is a British company that collaborates with medical professionals to bring ideas to life and create finished products. The private company is based in Leeds, UK. The company's focus is on transforming concepts into tangible solutions. Xiros was founded in 1982 by Bahaa Botros Seedhom and Kyosuke Fujikawa.

Aspect Biosystems Ltd. engages in 3D bio printing, tissue engineering and cell culture technologies. The company was founded by Simon Beyer, Sam Wadsworth, Konrad Walus and Tamer Mohamed in November 2013 and is headquartered in Vancouver, Canada.